NCCN Flash Updates™ Archive

NCCN Research & Business Resources

NCCN Flash Updates™ Archive

A subscription to NCCN Flash Updates™ provides for license to receive NCCN Content via NCCN Flash Updates™. NCCN Content, a valuable asset of NCCN which is protected by copyright, trademark and other proprietary rights is owned by NCCN. This subscription does not include license and/or permission to distribute NCCN Flash Updates and/or NCCN Content in any format.

Archive of past NCCN Flash Updates™

11/23/2009
Guidelines, Compendium for NHL Updated to Include Ofatumumab and Romidepsin

11/10/2009
NCCN Guidelines for Senior Adult Oncology Updated

11/5/2009
NCCN Guidelines for Small Cell Lung Cancer and for Breast Cancer Screening and Diagnosis Updated

11/3/2009
NCCN Guidelines for Kidney Cancer Updated to Include Pazopanib for Advanced Disease

10/27/2009
Updates Published to Five NCCN Guidelines - Melanoma, Hepatobiliary Cancers, Anal Carcinoma, Colorectal Cancer Screening, and Distress Management

10/14/2009
NHL Guidelines Updated with Addition of Pralatrexate for Peripheral T-cell Lymphoma (PTCL)

10/13/2009
Guidelines for Cervical Cancer Screening Updated and Published

10/8/2009
Ixabepilone added to Uterine Neoplasms Guideline; Cervical Cancer Guideline Also Updated

9/30/2009
Bladder Cancer Chapters Updated in NCCN Compendium

9/4/2009
Updates to NCCN Guidelines for Antiemesis v 4.2009

9/1/2009
Updates to NCCN Guidelines for Testicular Cancer and NCCN Compendium Chapters for Testicular Cancer and Kidney Cancer

8/31/2009
Updates to Guidelines for Bladder Cancer

8/28/2009
Updates to NCCN Guidelines for Kidney Cancer

8/5/2009
Trastuzumab added to NCCN Drugs & Biologics Compendium� for Gastric Cancer

8/5/2009
Updates to NCCN Guidelines for Cancer- and Chemotherapy- Induced Anemia and NCCN Guidelines for Occult Primary (Cancer of Unknown Primary)

8/3/2009
Updates to Myelodysplastic Syndromes (MDS) Guidelines

7/23/2009
NCCN Drugs & Biologics Compendium� Chapters for Neuroendocrine Tumors

7/23/2009
Prevention and Treatment of Cancer-Related Infections Guidelines Updated

7/8/2009
Prostate Cancer Early Detection Guidelines Updated to v.1.2010

6/23/2009
Multiple Myeloma Guidelines Updated with Numerous Changes to the NCCN Categories of Evidence and Consensus for Induction Therapy Regimens

6/8/2009
CML Guidelines Updated

6/1/2009
Head and Neck Cancers Guidelines updated to include option of PET-CT and CT with contrast in several cancer sites

5/28/2009
Octreotide therapy for asymptomatic patients with recurrent, unresectable carcinoid tumors added to Neuroendocrine Tumors Guidelines

4/28/2009
NCCN Clinical Practice Guidelines in Oncology� for Central Nervous System Cancers and Venous Thromboembolic Disease Updated

4/13/2009
Everolimus added to National Comprehensive Cancer Network (NCCN) Kidney Cancer Guidelines as subsequent therapy following failure of tyrosine kinase inhibitor therapy (TKI)

If your organization would like to license the NCCN Content for any purpose, please contact Marisa Getzewich. If you would like any further information concerning NCCN or the NCCN Content, please visit the NCCN Permissions Request Section.